The market
$250M+
invested by the two leading methane-to-protein ventures

Industrial viability at commercial volume has not been confirmed to date. EcoBioworks is built to change that — and in doing so, to establish a leadership position in the global alternative protein industry.

SCP is in high demand.
The market has already proven it.
The gap is opportunity.

Global protein demand — animal feed, aquaculture, livestock, and human nutrition — represents a market exceeding $1.5 trillion annually. SCP from methane is the only technology that can scale to meet it without land, water, or overfishing constraints.

Every landfill, every flare site, every biogas source becomes a profitable production facility. The feedstock is global, abundant, and largely wasted today. This is the foundation of a multi-billion-dollar platform.

Request Confidential Briefing See how we close the gap
EcoBioworks — biology at industrial scale
Our position

The biology is proven. We have the technology to confirm industrial viability — for a fraction of what the industry has spent pursuing it.

Since 2019, EcoBioworks has developed a deploy-ready 20,000 t/y single-cell protein facility. Biology is ready, redesigned with modern industrial technologies in mind.

While others spent hundreds of millions to demonstrate industrial scale, we engineered a path to the same destination for a fraction of the cost, based on existing technology.

The first facility monetizes pipeline natural gas. Landfill gas, associated gas and biogas follow once industrial technology is validated — opening a global deployment network scalable to millions of tons.

20,000 t/y
Facility capacity · engineering complete
<4 acres
Full facility footprint
1.8 Bcf/y
Methane monetized annually
>40% IRR
Target return · first facility
≥70%
Crude protein content
2019
Development started
The structure

Offtake confirmed.
Financing structured.
Ready to execute.

Offtake for the full 20,000 t/y capacity is confirmed before construction begins. 80% of the full facility is covered by low-interest government industrial financing, triggered by the seed close.

The first stage — approximately 10% of total project cost — validates the technology at industrial scale and unlocks all downstream capital. This is not a pilot. It is the first unit of a replicable global platform.

Engineering Complete
Full 20,000 t/y facility design finalized. Proven historical technology with modern industrial enhancements.
Complete
Seed Round
Raising now. Offtake confirmed. Institutional investors participation pending industrial lead validation.
Active · 2026
Stage 1 — Technology Validation
First stage of the industrial facility operational. Triggers FID and full government financing for the complete facility.
8–10 months from funding
Full 20,000 t/y Facility
Commercial production begins. Offtake deliveries. Engineering template ready for global replication.
18–20 months from funding
Full
20,000 t/y offtake confirmed before construction begins. Customers are committed.
80%
Low-interest government industrial financing of full facility. Triggered by seed close.
~10%
Stage 1 cost as a share of total project. Validates everything. Unlocks all downstream capital.
>40%
Target IRR on first deployment. Profitable from unit one. Without subsidies.
Seed Round

One position
defines the timeline.

A seed round is open to fund the first stage of the industrial facility — validating the technology and triggering 80% low-interest government financing for the full facility. Strategic institutional investors are committed. One industrial lead position defines the timeline for everyone behind them.

Industrial Lead — Anchor
The critical path. Validates the project for all downstream capital.
Sought
Strategic Institutional Investors
Co-investment · conditional pending industrial lead validation
Conditional
Government Industrial Financing
80% of full facility · low-interest · triggered by seed close
80%
Conditional

Capital structure, seed round size, and full project economics available under NDA to qualified investors.

Why the industrial lead is the key
The industrial lead does not merely co-invest — they validate the project for institutional investors and trigger the government financing structure. Their participation unlocks everything that follows.
What the industrial lead receives
Priority access to future facility investments and global replication opportunities. Input on deal structure. First-mover position in the only methane-to-protein platform with a validated path to millions of tons.
Contact
Request Confidential Briefing Roman Botcharnikov · CEO & Founder · +1 865 544-8989

Full project details, deployment location, capital structure, and partnership terms available under NDA.

Platform Team Contact Request Confidential Briefing